Predicted impact of extending the screening interval for diabetic retinopathy: The Scottish Diabetic Retinopathy Screening programme

Diabetologia

Volumn 56, Issue 8, 2013, Pages 1716-1725

  Looker, H C ^a   Nyangoma, S O ^a   Cromie, D T ^b   Olson, J A ^c   Leese, G P ^d   Philip, S ^e   Black, M W ^f   Doig, J ^g   Lee, N ^f   Briggs, A ^h   Hothersall, E J ^a   Morris, A D ^a   Lindsay, R S ⁱ   McKnight, J A ^j,k   Pearson, D W M ^c   Sattar, N A ⁱ   Wild, S H ^l   McKeigue, P ^l   Colhoun, H M ^a,m  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b NHS LANARKSHIRE   (United Kingdom)

^c ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

^e Grampian Diabetes Research Unit   (United Kingdom)

^f NHS HIGHLAND   (United Kingdom)

^g FORTH VALLEY ROYAL HOSPITAL   (United Kingdom)

^h UNIVERSITY OF GLASGOW   (United Kingdom)

ⁱ UNIVERSITY OF GLASGOW   (United Kingdom)

^j WESTERN GENERAL HOSPITAL   (United Kingdom)

^k UNIVERSITY OF EDINBURGH   (United Kingdom)

^l UNIVERSITY OF EDINBURGH   (United Kingdom)

^m NHS FIFE   (United Kingdom)

more..

Author keywords

Diabetes; Diabetic retinopathy; Maculopathy; Retinal screening; Screening intervals

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; HEALTH PROGRAM; HIDDEN MARKOV MODEL; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROLIFERATIVE RETINOPATHY; RETINA MACULOPATHY; RETROSPECTIVE STUDY; SCREENING; UNITED KINGDOM; VISUAL SYSTEM EXAMINATION;

ADULT; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; RETROSPECTIVE STUDIES; SCOTLAND; YOUNG ADULT;

EID: 84879978584     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-2928-7     Document Type: Article

References (26)

1. Kohner EM (1993) Diabetic retinopathy. BMJ 307:1195-1199
2. National diabetes retinopathy screening (2011). Available from www.ndrs.scot.nhs.uk/, accessed 6 October 2011
3. Facey K, Cummins E, Macpherson K, Morris K, Reay L, Slattery J (2002) Organisation of services for diabetic retinopathy screening. Health Technology Assessment Report 1. Health Technology Board for Scotland, Glasgow
4. Mitchell P, Bandello F, Schmidt-Erfurth U et al (2011) The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 118:615-625
5. Elman MJ, Aiello LP, Beck RW et al (2010) Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 117(1064-1077):e1035
6. Scottish Diabetic Retinopathy Screening Programme annual report 2010-2011. Available from www.ndrs.scot.nhs.uk/ExecGrp/Docs/ DRSP%20Annual%20Report%202010-2011.pdf, accessed 30 July 2012
7. Scottish Diabetes Survey 2011. Available from www.diabetesinscotland.org. uk/Publications/SDS%202011.pdf, accessed 1 October 2012
8. Aspelund T, Thornorisdottir O, Olafsdottir E et al (2011) Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy. Diabetologia 54:2525-2532
9. Agardh E, Tababat-Khani P (2011) Adopting 3-year screening intervals for sight-threatening retinal vascular lesions in type 2 diabetic subjects without retinopathy. Diabetes Care 34:1318-1319
10. Mehlsen J, Erlandsen M, Poulsen PL, Bek T (2012) Individualized optimization of the screening interval for diabetic retinopathy: a new model. Acta Ophthalmol 90:109-114
11. Thomas RL, Dunstan F, Luzio SD et al (2012) Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis. BMJ 344:e874
12. Younis N, Broadbent DM, Harding SP, Vora JP (2003) Incidence of sight-threatening retinopathy in type 1 diabetes in a systematic screening programme. Diabet Med 20:758-765
13. Younis N, Broadbent DM, Vora JP, Harding SP (2003) Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet 361:195-200
14. Jones CD, Greenwood RH, Misra A, Bachmann MO (2012) Incidence and progression of diabetic retinopathy during 17 years of a population-based screening program in England. Diabetes Care 35:592-596
15. Livingstone SJ, Looker HC, Hothersall EJ et al (2012) Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish Registry Linkage Study. PLoS Med 9:e1001321
16. Looker HC, Nyangoma SO, Cromie D et al (2012) Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland. Diabetologia 55:2335-2342
17. DRS (2007) The Scottish Diabetic Retinopathy Grading Scheme 2007 v1.1. Available from www.ndrs.scot.nhs.uk/ClinGrp/Docs/Grading%20Scheme%202007%20v1.1. pdf, accessed 30 July 2012
18. Development Core Team R (2009) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
19. Jackson C (2011) Multi-state models for panel data: the msm package for R. Journal of Statistical Software 38:1-28
20. Welcome to the English National Screening Programme for Diabetic Retinopathy (2012). Available from www.retinalscreening.nhs.uk/pages/, accessed 10 January 2012
21. Diabetic Retinopathy Screening Service for Wales (2012). Available from www.cardiffandvaleuhb.wales.nhs.uk/drssw, accessed 10 January 2012
22. Olafsdottir E, Stefansson E (2007) Biennial eye screening in patients with diabetes without retinopathy: 10-year experience. Br J Ophthalmol 91:1599-1601
23. Chalk D, Pitt M, Vaidya B, Stein K (2012) Can the retinal screening interval be safely increased to 2 years for type 2 diabetic patients without retinopathy? Diabetes Care 35:1663-1668
24. Goatman KA, Philip S, Fleming AD et al (2012) External quality assurance for image grading in the Scottish Diabetic Retinopathy Screening Programme. Diabet Med 29:776-783
25. Leese GP, Morris AD, Swaminathan K et al (2005) Implementation of national diabetes retinal screening programme is associated with a lower proportion of patients referred to ophthalmology. Diabet Med 22:1112-1115
26. Philip S, Cowie LM, Olson JA (2005) The impact of the Health Technology Board for Scotland's grading model on referrals to ophthalmology services. Br J Ophthalmol 89:891-896